Skip to content
Open access · CC-BY via OpenAlex

Twelve-month kinetics of circulating fibrosis-linked microRNAs (miR-21, miR-29, miR-30, and miR-133a) and the relationship with extracellular matrix fibrosis in dilated cardiomyopathy

Paweł Rubiś, Justyna Totoń‐Żurańska, Maria Kołton‐Wróż, Paweł P. Wołkow, Ewelina Pitera, Sylwia Wiśniowska‐Śmiałek, Ewa M. Dziewięcka, Ann C. Garlitski, Piotr Stanisław Podolec

Archives of Medical Science · 2019 · ▲ 5 citations

Abstract

Introduction A single measurement of any biomarker may not reflect its full biological meaning. The kinetics of fibrosis-linked microRNAs and their relationship with extracellular matrix (ECM) fibrosis in dilated cardiomyopathy (DCM) have not been explored. Material and methods We evaluated 70 consecutive DCM patients (48 ±12.1 years, left ventricular ejection fraction 24.4 ±7.4%). All patients underwent right ventricular endomyocardial biopsy in order to quantify ECM fibrosis and measure collagen volume fraction (CVF). Circulating microRNAs (miR-21-5p, miR-29b, miR-30c-5p, and miR-133a-3p) were measured with quantitative polymerase chain reaction (PCR) at baseline and at 3 and 12 months. Results Based on the biopsy results, two groups of patients were identified: with (n = 24, 34.3%) and without (n = 46, 65.7%) ECM fibrosis. Except for a single measurement of miR-29b at 3 months (DCM with fibrosis: 6.03 ±0.72 vs. DCM without fibrosis: 6.4 ±0.75 Cq; p < 0.05), baseline, 3- and 12-month kinetics of microRNAs did not differ between the two groups. Moreover, 12-month microRNA kinetics did not differ in patients with new-onset DCM (duration < 6 months; n = 35) and chronic DCM (> 6 months; n = 35). Only miR-29 at 3 months correlated with CVF (r = –0.31; p < 0.05), whereas other microRNAs did not correlate with CVF either at 3 or at 12 months. Conclusions Regardless of ECM fibrosis status or duration of the disease, 12-month patterns of circulating microRNAs are similar in DCM. Correlations between microRNAs, measured at 3 and 12 months, are lower than expected. In this study, regardless of the time point, circulating microRNAs were not able to differentiate between DCM patients with versus without fibrosis.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.5114/aoms.2019.89777
Canonical
link ↗
Fetched
2026-10-25 MST

Cite this

APA
Rubiś, P., Totoń‐Żurańska, J., Kołton‐Wróż, M., Wołkow, P.P., Pitera, E., Wiśniowska‐Śmiałek, S., Dziewięcka, E.M., Garlitski, A.C., &amp; Podolec, P.S. (2019). Twelve-month kinetics of circulating fibrosis-linked microRNAs (miR-21, miR-29, miR-30, and miR-133a) and the relationship with extracellular matrix fibrosis in dilated cardiomyopathy. <em>Archives of Medical Science</em>. https://doi.org/10.5114/aoms.2019.89777
Vancouver
Rubiś P, Totoń‐Żurańska J, Kołton‐Wróż M, Wołkow PP, Pitera E, Wiśniowska‐Śmiałek S, et al. Twelve-month kinetics of circulating fibrosis-linked microRNAs (miR-21, miR-29, miR-30, and miR-133a) and the relationship with extracellular matrix fibrosis in dilated cardiomyopathy. Archives of Medical Science. 2019. doi:10.5114/aoms.2019.89777.
BibTeX
@article{pawe2019Twelve, title = {Twelve-month kinetics of circulating fibrosis-linked microRNAs (miR-21, miR-29, miR-30, and miR-133a) and the relationship with extracellular matrix fibrosis in dilated cardiomyopathy}, author = {Paweł Rubiś and Justyna Totoń‐Żurańska and Maria Kołton‐Wróż and Paweł P. Wołkow and Ewelina Pitera and Sylwia Wiśniowska‐Śmiałek and Ewa M. Dziewięcka and Ann C. Garlitski and Piotr Stanisław Podolec}, journal = {Archives of Medical Science}, year = {2019}, doi = {10.5114/aoms.2019.89777}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings